Eli Lilly's acquisition of psychedelic drug maker AtaiBeckley extends Big Pharma's embrace of a stigmatized class of ...

Twelve years ago, Christian Angermayer took a mushroom trip that inspired him to try to create FDA-approved medicines from ...

Eli Lilly's acquisition of AtaiBeckley for up to $3.8 billion, marks a pivotal moment for psychedelic medicine.

Lilly's purchase of AtaiBeckley is yet another strategic move in its bid to diversify its pipeline.

Watch to see why companies are betting big on the therapeutic potential of a toad poison.

Long before scientists began studying them in the lab, mind-altering substances were already being gathered from plants, ...

An in-depth look at the leading psychedelic stocks in the U.S. stock market this year. Here's what you need to know.

Ezell is a social epidemiologist and assistant professor at the University of Chicago Medical Center. Choi is a health services researcher and assistant professor at New York University Grossman ...

On display through December at YIVO and the Center for Jewish History, visual artist Steve Marcus’s work brings together ...

The bassist went on to say that Carter came up with the lyrics, which he described as "odd" and "pretty cool," with the help ...

The popular chain once had locations in Lexington for almost 20 years. Now, new locations are returning in and around the ...

These three psychedelic rock albums helped define the subgenre in the 1960s. Without these records, this subgenre might never ...